Bioventus Inc. (BVS) vs Enovis Corporation (ENOV)
Bioventus Inc. and Enovis Corporation are both Medical Devices companies. Bioventus Inc. and Enovis Corporation are of similar size ($1.1B and $1.1B). Enovis Corporation has negative trailing earnings, so its P/E is not meaningful; Bioventus Inc. trades at 17.0×. Enovis Corporation grew revenue faster over the last twelve months: 4.89% against 3.14%. Bioventus Inc. has the higher net margin (9.36% vs −48.0%) and the higher return on invested capital (7.34% vs −23.6%). Across the 21 metrics below, Bioventus Inc. leads on 13 and Enovis Corporation on 8.
Valuation
Profitability
| Metric | BVS | ENOV | Medical Devices median |
|---|---|---|---|
| Gross margin | 68.65% | 61.09% | 56.01% |
| Operating margin | 10.02% | (45.14%) | (15.03%) |
| Net margin | 9.36% | (47.97%) | (20.40%) |
| Free cash flow margin | 16.20% | 2.77% | (7.24%) |
| Return on equity | 22.75% | (54.27%) | (15.32%) |
| Return on assets | 7.89% | (25.07%) | (19.72%) |
| Return on invested capital | 7.34% | (23.55%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack